Sanjay R Kalliat, M Alejandro Valdes-Pena, Joshua G Pierce
The opportunistic nature of S. aureus, along with its tendency to develop resistance to antibiotics and ability to form biofilms readily, makes it a challenging pathogen to treat. This underscores the need for novel, evolving therapeutics. We report a new generation of pyrrolidine-2,3-dione monomers, accessed via a multicomponent reaction, with exciting antimicrobial and antibiofilm activities. The presence of a para-trifluoromethyl substituent on the scaffold's N-aryl substituent improved the biological profile of these analogs relative to previous generations.